top of page
  • Writer's pictureDr. Dan Jin

PBG BioPharma actively developing cannabis-based products against SARS-CoV-2

Updated: Sep 13, 2023

The COVID-19 pandemic has had broad global ramifications and, while vaccine development is progressing, supplemental or alternative treatments for the virus are also crucial. PBG BioPharma has received Health Canada approved cannabis research license which allows us to research the potential therapeutical effects of Cannabis derived phytochemicals in the treatment or prevention of multi-viral infections, including SARS-Cov-2.


1 view0 comments

Comments


PARTNER WITH US

Got a project?
Let’s talk.

We’re a team of scientists who are excited about unique ideas and help cannabis companies realize their product vision. 

Nutritional Supplements white label manufacturing - PBG
bottom of page